A non-profit organization called AfghanEvac is demanding an investigation into the death of Mohommad Nazeer Paktyawal, 41, an Afghan asylum seeker who served asA non-profit organization called AfghanEvac is demanding an investigation into the death of Mohommad Nazeer Paktyawal, 41, an Afghan asylum seeker who served as

Soldier's death in ICE detention raises questions

2026/03/17 13:05
1 min read
For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

A non-profit organization called AfghanEvac is demanding an investigation into the death of Mohommad Nazeer Paktyawal, 41, an Afghan asylum seeker who served as a special forces soldier and fought alongside U.S. Army Special Forces for over a decade.

Paktyawal was detained by Immigration and Customs Enforcement officers in Dallas while preparing to take his six children to school and died within 24 hours. He was admitted to Parkland Hospital on March 13 at 11:45 p.m. and pronounced dead March 14 at noon.

AfghanEvac states it is highly unusual for a healthy 41-year-old to die so suddenly in government custody and is calling for transparent investigation by the Department of Homeland Security Inspector General and Congress.

The family expressed shock at his sudden death, with children asking when their father will return home.

Watch the video below.

Your browser does not support the video tag.

Market Opportunity
Overtake Logo
Overtake Price(TAKE)
$0.02175
$0.02175$0.02175
-0.22%
USD
Overtake (TAKE) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.